Literature DB >> 32255160

Non-viral nanocarriers for intracellular delivery of microRNA therapeutics.

Zhiman Bai1, Jing Wei, Changmin Yu, Xisi Han, Xiaofei Qin, Chengwu Zhang, Wenzhen Liao, Lin Li, Wei Huang.   

Abstract

MicroRNAs are small regulatory noncoding RNAs that regulate various biological processes associated with neurological disorders, cardiovascular diseases, cancer and viral infection. MiRNA-based therapeutics have broad applications including cancer immunotherapy, genomic engineering and protein replacement therapy. Until now, a variety of materials have been proved to be promising as non-viral nanocarriers for intracellular delivery of miRNAs, such as polymeric nanoparticles, lipid nanocapsules, and inorganic nanoparticles, etc. In this review, we will present the strategies for intracellular miRNA delivery, and specially focus on rationally designed routes, their mechanisms of action, and potential therapeutics used in the host cells or in vivo studies. Futhermore, we will also make a conclusion based on the current development. The perspective on the new generation of delivery systems toward the emerging area of miRNA-based therapeutics will be discussed as well.

Entities:  

Year:  2019        PMID: 32255160     DOI: 10.1039/c8tb02946f

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  23 in total

1.  Co-delivery of miRNA-15a and miRNA-16-1 using cationic PEGylated niosomes downregulates Bcl-2 and induces apoptosis in prostate cancer cells.

Authors:  Maedeh Ghaffari; Seyed Mehdi Kalantar; Mahdie Hemati; Ali Dehghani Firoozabadi; Amir Asri; Ali Shams; Sina Jafari Ghalekohneh; Fateme Haghiralsadat
Journal:  Biotechnol Lett       Date:  2021-01-30       Impact factor: 2.461

Review 2.  MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies.

Authors:  Mamta Panda; Elora Kalita; Satyendra Singh; Ketan Kumar; Abhishek Rao; Vijay Kumar Prajapati
Journal:  Life Sci       Date:  2022-07-01       Impact factor: 6.780

Review 3.  Surface Modification of Iron Oxide-Based Magnetic Nanoparticles for Cerebral Theranostics: Application and Prospection.

Authors:  Yanyue Wu; Zhiguo Lu; Yan Li; Jun Yang; Xin Zhang
Journal:  Nanomaterials (Basel)       Date:  2020-07-24       Impact factor: 5.076

Review 4.  MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside.

Authors:  Margherita Ratti; Andrea Lampis; Michele Ghidini; Massimiliano Salati; Milko B Mirchev; Nicola Valeri; Jens C Hahne
Journal:  Target Oncol       Date:  2020-06       Impact factor: 4.493

Review 5.  MicroRNAs in Chronic Kidney Disease: Four Candidates for Clinical Application.

Authors:  Linsey J F Peters; Jürgen Floege; Erik A L Biessen; Joachim Jankowski; Emiel P C van der Vorst
Journal:  Int J Mol Sci       Date:  2020-09-07       Impact factor: 5.923

Review 6.  The potential of miRNA-based therapeutics in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection: a review.

Authors:  Leonny Dwi Rizkita; Indwiani Astuti
Journal:  J Pharm Anal       Date:  2021-03-24

Review 7.  COVID-19: fighting the invisible enemy with microRNAs.

Authors:  Neeraj Chauhan; Meena Jaggi; Subhash C Chauhan; Murali M Yallapu
Journal:  Expert Rev Anti Infect Ther       Date:  2020-09-16       Impact factor: 5.091

Review 8.  From animal models to patients: the role of placental microRNAs, miR-210, miR-126, and miR-148a/152 in preeclampsia.

Authors:  Sonya Frazier; Martin W McBride; Helen Mulvana; Delyth Graham
Journal:  Clin Sci (Lond)       Date:  2020-04-30       Impact factor: 6.124

Review 9.  MicroRNA Nanotherapeutics for Lung Targeting. Insights into Pulmonary Hypertension.

Authors:  Susana Carregal-Romero; Lucía Fadón; Edurne Berra; Jesús Ruíz-Cabello
Journal:  Int J Mol Sci       Date:  2020-05-04       Impact factor: 5.923

Review 10.  MicroRNAs as Modulators of Oral Tumorigenesis-A Focused Review.

Authors:  Kumar Rishabh; Soham Khadilkar; Aviral Kumar; Ishu Kalra; Alan Prem Kumar; Ajaikumar B Kunnumakkara
Journal:  Int J Mol Sci       Date:  2021-03-04       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.